Citius Pharmaceuticals (CTXR) Return on Equity [ROE] (2016 - 2026)
Citius Pharmaceuticals (CTXR) recorded Return on Equity [ROE] of -80.23% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 16.07 percentage points from -64.17% a year earlier and down 12.01 percentage points from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals reported Return on Equity [ROE] of -52.42%, down 4.78 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four straight fiscal years, though with a five-year change of +5.28 percentage points (FY2020 to FY2025).
- Across earlier fiscal years, Return on Equity [ROE] came in at -47.63% in FY2024 (-14.23 pp), -33.40% in FY2023 (-4.92 pp), -28.48% in FY2022 (-0.78 pp) and -27.70% in FY2021 (+30.00 pp).
- The fiscal Q3 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to fiscal Q2 2016.
- On a year-over-year basis, Return on Equity [ROE] rose in two of the last eight quarters, with an average year-over-year change of -5.56 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 52.94 percentage points in fiscal Q1 2022, against a drop of 40.17 percentage points in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -68.23% (Q2 2026), -45.44% (Q1 2026) and -54.78% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Citius Pharmaceuticals | 13.45 Mn | -10.82 Mn | 1.00 Mn | -80.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -80.87% |
| Mar 31, 2026 | -71.63% |
| Dec 31, 2025 | -47.24% |
| Jun 30, 2025 | -63.40% |
| Mar 31, 2025 | -61.75% |
| Dec 31, 2024 | -54.02% |
| Jun 30, 2024 | -46.07% |
| Mar 31, 2024 | -43.80% |
| Dec 31, 2023 | -43.20% |
| Sep 30, 2023 | -71.11% |
| Jun 30, 2023 | -65.31% |
| Mar 31, 2023 | -31.53% |
| Dec 31, 2022 | -26.83% |
| Sep 30, 2022 | -30.94% |
| Jun 30, 2022 | -26.94% |
| Mar 31, 2022 | -22.90% |
| Dec 31, 2021 | -18.93% |
| Sep 30, 2021 | -17.24% |
| Jun 30, 2021 | -16.94% |
| Mar 31, 2021 | -27.80% |
API Access
Citius Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();